确定CPLX1表达作为结直肠癌潜在预后标志物的鉴定
Li Jin1, Lili Qian1, Xin Zhang1
1Cancer Center, Department of Pathology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
Molecular and cellular probes
|July 12, 2025
概括
复合素-1 (CPLX1) 过度表达与结直肠癌 (CRC) 的预后不佳相关. 这项研究确定CPLX1是CRC的潜在预后和诊断标记物,建议它作为治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 复合素-1 (CPLX1) 与瘤进展有关,但其在结直肠癌 (CRC) 中的具体作用尚不清楚.
- 了解CRC中CPLX1的生物机制对于开发向疗法至关重要.
研究的目的:
- 研究CPLX1在结直肠癌中的表达,预后价值和潜在的生物功能.
- 探索CPLX1与CRC中的免疫透之间的关联.
主要方法:
- 在泛癌和CRC数据集 (TIMER,TCGA) 中分析CPLX1mRNA表达.
- 在90个CRC和相邻的正常组织上进行免疫组织化学 (IHC),以评估CPLX1蛋白水平和临床相关性.
- 使用考克斯回归和卡普兰-梅尔分析进行预测价值评估.
- 通过斯皮尔曼分析探索CPLX1与免疫细胞透和检查点的关联.
- 基因组丰富分析 (GSEA) 以确定与CPLX1相关的分子功能.
主要成果:
- 在CRC组织中,CPLX1mRNA和蛋白质表达升高.
- 过度表达CPLX1显着与晚期T阶段和较差的整体存活率 (OS),疾病特异性存活率 (DSS) 和无进展间隔 (PFI) 相关.
- CPLX1表达在CRC中具有预后价值,并且与免疫细胞透有关,相关基因参与了Notch信号通路.
结论:
- CPLX1作为结直肠癌的潜在预后和诊断生物标志物.
- 在CRC治疗中,CPLX1可能是一个有前途的治疗标.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K


